Cargando…
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds
PURPOSE: Dichloroacetate (DCA) inhibits pyruvate dehydrogenase kinase (PDK), and thus promotes glucose oxidation over glycolysis and induces apoptotic death of tumor cells. The present study investigated the potential of DCA to increase the antitumor effects of platinum- based compounds against a pa...
Autores principales: | Olszewski, Ulrike, Poulsen, Thomas Tuxen, Ulsperger, Ernst, Poulsen, Hans Skovgard, Geissler, Klaus, Hamilton, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262384/ https://www.ncbi.nlm.nih.gov/pubmed/22291503 http://dx.doi.org/10.2147/CPAA.S11795 |
Ejemplares similares
-
Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells
por: Olszewski, Ulrike, et al.
Publicado: (2011) -
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
por: Olszewski, Ulrike, et al.
Publicado: (2009) -
Inhibition of the hyaluronan matrix enhances metabolic anticancer therapy by dichloroacetate in vitro and in vivo
por: Twarock, Sören, et al.
Publicado: (2019) -
Two mixed-NH(3)/amine platinum (II) anticancer complexes featuring a dichloroacetate moiety in the leaving group
por: Liu, Weiping, et al.
Publicado: (2013) -
Improving the anticancer activity of platinum(iv) prodrugs using a dual-targeting strategy with a dichloroacetate axial ligand
por: Liu, Fengfan, et al.
Publicado: (2019)